Back to search
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nintedanib, ATC L01EX09
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPublished on Mar 15, 2026
537 days left
GermanyDescription
Conclusion of non-exclusive rebate contracts pursuant to §§ 130a para. 8/130c para. 1 SGB V for medicines with the aforementioned active ingredient within the period from 01.05.2026 to 30.04.2028 with the possibility of concluding the contract at any time (open-house model). In the open-house procedure, medicines are excluded according to the BfArM list pursuant to § 35 para. 5a SGB V (paediatric medicines).
CPV codes
Pharmaceutical products
Documents & submission
AI summary
Sign in for an AI summaryContains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 28 - Hepatitis-B-Immunglobulin (ATC-Code J06BB04)
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 782 daysPublished on Sep 09, 2026
Germany – X-ray devices – Beschaffung einer Röntgenanlage für Asklepios Nordseeklinik Westerland
Asklepios Nordseeklinik GmbH - Asklepios Nordseeklinik WesterlandGermanyX-ray devicesDeadline in 29 daysPublished on Sep 09, 2026
Germany – Paper sanitary – Abfallsäcke und Hygienepapier
Landschaftsverband Westfalen-LippeGermanyPaper sanitaryPolythene waste and refuse sacks and bagsDeadline in 32 daysPublished on Sep 09, 2026
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
KKH Kaufmännische KrankenkasseGermanyPharmaceutical productsDeadline in 112 daysPublished on Sep 08, 2026